Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vitrafy's patented cryopreservation platform improves post-thaw recovery rates of sensitive biological materials. In a recent two-phase study with a leading national blood service provider, their process achieved 72% fertilization rates post-thaw compared to 0–40% with regular methods and 76% with fresh samples. The solution is being applied to critical healthcare needs such as emergency platelet supply and advanced cell therapies like CAR T-cells.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vitrified.